Thrombosis odds up with bioresorbable vascular scaffolds
(HealthDay)—Everolimus-eluting bioresorbable vascular scaffolds (BVSs) are associated with increased odds of scaffold thrombosis and other thrombotic events compared with everolimus-eluting metallic stents (EESs), according ...
Oct 17, 2017
0
0